Shriram Revankar Sells 3,000 Shares of Dolby Laboratories (NYSE:DLB) Stock

Dolby Laboratories (NYSE:DLB) SVP Shriram Revankar sold 3,000 shares of the business’s stock in a transaction that occurred on Friday, August 14th. The shares were sold at an average price of $62.71, for a total value of $188,130.00. Following the completion of the transaction, the senior vice president directly owned 73,274 shares in the company, valued at approximately $4,595,012.54. This trade represents a 3.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Dolby Laboratories Stock Performance

Shares of DLB stock traded down $0.13 during trading hours on Tuesday, hitting $61.22. 517,386 shares of the company were exchanged, compared to its average volume of 822,352. The firm has a market cap of $5.73 billion, a P/E ratio of 26.05 and a beta of 0.80. Dolby Laboratories has a fifty-two week low of $48.26 and a fifty-two week high of $75.66. The company has a 50 day simple moving average of $53.67 and a two-hundred day simple moving average of $58.46.

Dolby Laboratories (NYSE:DLB) last released its earnings results on Thursday, July 30th. The electronics maker reported $0.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.67 by $0.02. The company had revenue of $305.00 million for the quarter, compared to the consensus estimate of $311.96 million. Dolby Laboratories had a net margin of 16.70% and a return on equity of 11.08%. Dolby Laboratories’s quarterly revenue was down 3.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.78 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. As a group, sell-side analysts expect that Dolby Laboratories will post 3.26 EPS for the current fiscal year.

Dolby Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 19th. Stockholders of record on Tuesday, August 11th will be issued a dividend of $0.36 per share. The ex-dividend date is Tuesday, August 11th. This represents a $1.44 annualized dividend and a dividend yield of 2.4%. Dolby Laboratories’s dividend payout ratio is currently 61.28%.

Dolby Laboratories declared that its Board of Directors has authorized a stock repurchase plan on Thursday, July 30th that authorizes the company to buyback $350.00 million in outstanding shares. This buyback authorization authorizes the electronics maker to reacquire up to 7% of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s management believes its shares are undervalued.

Hedge Funds Weigh In On Dolby Laboratories

A number of hedge funds have recently added to or reduced their stakes in the stock. Paragon Capital Management Inc. bought a new position in shares of Dolby Laboratories in the first quarter valued at approximately $1,306,000. Teacher Retirement System of Texas grew its holdings in Dolby Laboratories by 19.1% during the fourth quarter. Teacher Retirement System of Texas now owns 115,772 shares of the electronics maker’s stock worth $7,435,000 after buying an additional 18,579 shares in the last quarter. Hsbc Holdings PLC grew its holdings in Dolby Laboratories by 396.1% during the first quarter. Hsbc Holdings PLC now owns 31,259 shares of the electronics maker’s stock worth $1,875,000 after buying an additional 24,958 shares in the last quarter. Norges Bank purchased a new stake in Dolby Laboratories in the 4th quarter valued at $54,966,000. Finally, Entropy Technologies LP purchased a new stake in Dolby Laboratories in the 1st quarter valued at $1,674,000. Institutional investors and hedge funds own 58.56% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently commented on DLB shares. Weiss Ratings lowered Dolby Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday. Wall Street Zen lowered Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. Rosenblatt Securities reissued a “buy” rating and issued a $85.00 price objective on shares of Dolby Laboratories in a research note on Friday, July 31st. Finally, Barrington Research restated an “outperform” rating and set a $90.00 price objective on shares of Dolby Laboratories in a report on Monday, June 15th. Two investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $83.00.

About Dolby Laboratories

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.